Individualized Risk of CKD Progression among US Adults
Open Access
- 15 May 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 35 (8) , 1076-1083
Abstract
Key Points: A total of 8.42 million US adults have high CKD progression risk, and 4.77 million of them have eGFR >60 ml/min per 1.73 m2. An individual's absolute risk of CKD progression is important in the diagnosis and prognostication of CKD. Background: CKD is currently defined using GFR or albuminuria. This is on the basis of the relative risk of mortality and kidney outcomes compared with a healthy population and does not consider an individual's absolute risk of CKD progression. Methods: Using National Health and Nutrition Examination Survey data from 1999 to 2020, we characterized the individual-level absolute 3-year risk of ≥40% decline in eGFR (ml/min per 1.73 m2) or kidney failure (3-year risk) among US adults. We categorized the 3-year risk and considered ≥5% as high risk. Results: Among 199.81 million US adults, 8.42 million (4%) had a 3-year risk ≥5%, including 1.04 million adults without CKD (eGFR ≥60 and albuminuria <30 mg/g). These high-risk adults without CKD as currently defined had risk factors including hypertension (98%), heart failure (72%), and diabetes (44%). A total of 15.51 million adults had CKD with preserved eGFR (eGFR ≥60 and albuminuria ≥30 mg/g)—3.73 million had a 3-year risk ≥5%, 41% of whom did not have diabetes and thus would not be screened for albuminuria using current screening recommendations. The 3-year risk of CKD progression was low (risk <5%) in 94% of the 5.66 million US adults with CKD stage G3a-A1 (eGFR 45 to <60 and albuminuria <30 mg/g). Conclusions: Assessment of the individual's absolute risk of CKD progression allowed further risk stratification of patients with CKD and identified individuals without CKD, as currently defined, who were at high risk of CKD progression. Podcast: This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2024_06_18_ASN0000000000000377.mp3Keywords
Funding Information
- NIH (U54GM11542)
- NIH (U54GM11542)
- NIH (U54GM11542)
- NIH (R01-DK095668)
- NIH (K24-DK091419)
- NIH (R01-DK078106)
- NIH (R01NR017399)
- NIH (R01DK123062)
- NIH (U01DK127918)
- NIH (R01HL153499)
- NIH (U54GM11542)
- NIH (U54GM11542)
- NIH (U54GM11542)
- NIH (R01-DK095668)
- NIH (K24-DK091419)
- NIH (R01-DK078106)
- NIH (R01NR017399)
- NIH (R01DK123062)
- NIH (U01DK127918)
- NIH (R01HL153499)
This publication has 30 references indexed in Scilit:
- Development and External Validation of a Machine Learning Model for Progression of CKDKidney International Reports, 2022
- Epidemiology of chronic kidney disease: an update 2022Kidney International Supplements, 2022
- Derivation and validation of a machine learning risk score using biomarker and electronic patient data to predict progression of diabetic kidney diseaseDiabetologia, 2021
- The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKidney International, 2021
- Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortalityKidney International, 2017
- Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney FailureJAMA, 2016
- Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohortsKidney International, 2011
- The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference reportKidney International, 2011
- A Predictive Model for Progression of Chronic Kidney Disease to Kidney FailureJAMA, 2011
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010